As studies continue to mount linking the NuvaRing contraceptive to blood clots, and more than 1,500 women have already filed lawsuits against the manufacturer, a judge is finally giving those injured their day in court.
Last month, U.S. District Judge Rodney Sippel scheduled the first of many NuvaRing lawsuit trials to begin on January 27, 2014.
NuvaRing became a popular alternative to birth control pills after its launch in 2000, since women could implant the small, flexible ring themselves for up to a month of prevention. And, the device has proven to be up to 99% effective.
However, experts now question whether the constant and direct absorption of chemical hormones into the bloodstream may be more likely to cause blood clots than oral contraceptives, which deliver small doses at different times.
In 2012, the British Medical Journal and New England Journal of Medicine published studies raising concerns over NuvaRing blood clots. They measured that patients using the devices could have a 200% to 300% increased risk of blood clots.
Also FDA records which track the number of patients or doctors who have filed an adverse event report show nearly 3,000 women have already suffered a blood clot injury linked to NuvaRing.
While clots can be a natural bodily defense, they can also cause dangerous or fatal situations like deep vein thrombosis (DVT), pulmonary embolism or stroke.
So far, Neither Organon Pharmaceuticals, who makes NuvaRing, nor parent company Merck have properly warned women that they may face such dangers by using NuvaRing.
The number of claims from victims has grown quickly, leading to the creation of a special multidistrict litigation court to handle claims. Now, a judge has ruled that those injured can seek compensation through a NuvaRing lawsuit.
The latest records show 1,358 cases in the federal court and hundreds more in a New Jersey state court. However, with the New Jersey judge dismissing many of the claims before him, DrugRisk recommends victims choose the federal venue.
Lawyers are still helping those injured by NuvaRing blood clots. If you or a loved one experienced a stroke, DVT or pulmonary embolism, you may be entitled to compensation from Merck. It is important to learn your options and it costs nothing to speak with a lawyer.
DrugRisk only recommends lawyers and law firms who have handled these type of NuvaRing lawsuits. Contact us today for more information on the research, side effects and litigation news related to NuvaRing, or to speak with a lawyer.